TIDES USA: Oligonucleotide & Peptide Therapeutics 2027
TIDES USA is North America's annual conference on oligonucleotide, mRNA and peptide therapeutics, from discovery through manufacturing. It draws scientists, CMC and analytical specialists, and business development teams from biopharma and their suppliers.
Monday to Thursday · 4 days
Hynes Convention Center
Organizer
Published by the organizer
Every year
How often it's held
Checked October 19, 2026
About TIDES USA: Oligonucleotide & Peptide Therapeutics 2027
TIDES USA is Informa Connect's annual North American conference on oligonucleotide, peptide, mRNA and genome editing therapeutics. The 2027 edition runs 26 to 29 April at the Hynes Convention Center in Boston. It's built for drug discovery scientists, CMC and analytical teams, and the suppliers and manufacturers who serve them. The organizer says the event typically attracts more than 2,000 attendees. Its 2026 list named 52 sponsors and 88 exhibitors, by our count.
200+
Industry speakers
170+
Sponsors (organizer figure)
8
Pre-conference workshops
55
Speakers listed so far (our count)
88
Exhibitors listed (our count)
500+
Companies attending
What happens at TIDES USA
TIDES USA combines a scientific conference, pre-conference workshops, a poster program and an exhibit hall. The official site lists 200+ industry speakers, eight workshops and more than 200 presentations.
The main program covers six concurrent tracks, according to the event home page. They're Oligonucleotide CMC, Oligonucleotide Discovery, Peptide Discovery, Peptide CMC, mRNA and Genome Editing, and Drug Delivery.
Monday 26 April is the pre-conference day, with morning and afternoon workshops. The main conference with keynotes and tracks runs from 27 to 29 April.
Delegates can add the Obesity Science & Innovation workshop on 30 April. It covers GLP-1 and multi-agonist therapies, RNA approaches to obesity and investment trends.
Researchers can present a scientific poster as a paid add-on to a conference pass. The 2027 abstract deadline is 29 March 2027.
What's new for TIDES USA 2027
The 2027 edition moves to late April, from mid-May in 2026. The early keynote lineup adds speakers from PeptiDream, Biogen, Intellia and Aralez Bio.
The Obesity Science & Innovation workshop is offered as a post-conference add-on on 30 April. Its agenda covers GLP-1 therapies, siRNA for metabolic targets and dealmaking.
Who attends TIDES USA
TIDES USA draws scientists, executives, engineers and decision-makers who develop and make oligonucleotide and peptide drugs. That's how the organizer's FAQ on the event site describes its audience of 2,000+.
- Diamond4
- Event Partners3
- Gold7
- Silver12
- Bronze26
Our count of the official 2026 sponsor list, 2 November 20262026 · informaconnect.com ↗
The same FAQ names researchers in oligonucleotide, mRNA and peptide therapeutics, plus drug discovery, development and commercialization staff. Experts in analytical development, manufacturing and delivery technologies also attend.
Pricing rules show the buyer mix. The industry rate is for members of pharmaceutical or biotechnology organizations, with separate academic, government and young company rates.
The last published headcount with a year is from 2023. The organizer's TIDES USA 2023 post-event report counted more than 1,700 attendees from over 500 companies in San Diego.
For 2026, Nucleic Acid Insights expected over 1,900 attendees in Boston. The organizer doesn't publish a breakdown by job function, seniority, company size or country.
Many of the same suppliers travel to TIDES Europe and to CPHI North America for pharma outsourcing.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| 2023 | 1,700+attendeesOrganizer post-event report for TIDES USA 2023 in San Diego, from over 500 companies.informaconnect.com ↗ |
| Not stated | 2,000+attendeesThe organizer says the event typically attracts more than 2,000 people, without a year.informaconnect.com ↗ |
Companies exhibiting and speaking at TIDES USA 2026 and 2027
Contract manufacturers, chromatography and synthesis suppliers, and analytical labs dominate the 2026 sponsor and exhibitor list. Drug developers mostly appear on the speaker list.
Sponsors (33)Agilent Technologies, Asymchem, Nitto Avecia and 30 more
- Agilent Technologies · 2026Diamond sponsor
- Asymchem · 2026Diamond sponsor
- Nitto Avecia · 2026Diamond sponsor
- WuXi TIDES · 2026Diamond sponsor
- Asahi Kasei Bioprocess · 2026Gold sponsor
- Bachem · 2026Gold sponsor
- BioSpring · 2026Gold sponsor
- Codexis · 2026Gold sponsor
- Samyang · 2026Gold sponsor
- ST Pharm · 2026Gold sponsor
- Sumitomo · 2026Gold sponsor
- Aldevron · 2026Silver sponsor
- Cambrex · 2026Silver sponsor
- CordenPharma · 2026Silver sponsor
- CPC Scientific · 2026Silver sponsor
- Cytiva · 2026Silver sponsor
- Fluid Air · 2026Silver sponsor
- Kinovate · 2026Silver sponsor
- LBB Specialties · 2026Silver sponsor
- LGC Biosearch Technologies · 2026Silver sponsor
- Neuland Labs · 2026Silver sponsor
- SK pharmteco · 2026Silver sponsor
- Tedia · 2026Silver sponsor
- Ajinomoto Bio-Pharma Services · 2026Bronze sponsor
- Croda Pharma · 2026Bronze sponsor
- DuPont · 2026Bronze sponsor
- Entegris · 2026Bronze sponsor
- GenScript · 2026Bronze sponsor
- Ionis Pharmaceuticals · 2026Bronze sponsor
- Phenomenex · 2026Bronze sponsor
- Thermo Fisher Scientific · 2026Bronze sponsor
- Veranova · 2026Bronze sponsor
- Waters Corporation · 2026Bronze sponsor
Partners (4)Axolabs, Hongene Biotech, PolyPeptide Group and 1 more
Exhibitors (12)Almac Group, Bruker, Evonik and 9 more
- Almac Group · 2026Exhibitor
- Bruker · 2026Exhibitor
- Evonik · 2026Exhibitor
- Shimadzu Scientific Instruments · 2026Exhibitor
- Promega · 2026Exhibitor
- Revvity · 2026Exhibitor
- TriLink Biotechnologies · 2026Exhibitor
- Eurofins BioPharma Product Testing · 2026Exhibitor
- Vetter Pharma · 2026Exhibitor
- YMC America · 2026Exhibitor
- Nagase · 2026Booth 431, API CDMO services
- Recipharm Advanced Bio · 2026Booth and presentation
Speakers' companies (12)Eli Lilly and Company, Moderna, Biogen and 9 more
- Eli Lilly and Company · 2027Company of a confirmed 2027 speaker
- Moderna · 2027Company of a confirmed 2027 speaker
- Biogen · 2027Company of a confirmed 2027 speaker
- Alnylam Pharmaceuticals · 2027Company of a confirmed 2027 speaker
- PeptiDream · 2027Company of a confirmed 2027 speaker
- Intellia Therapeutics · 2027Company of a confirmed 2027 speaker
- Novo Nordisk · 2027Company of a confirmed 2027 speaker
- Merck · 2027Company of a confirmed 2027 speaker
- Prime Medicine · 2027Company of a confirmed 2027 speaker
- Beam Therapeutics · 2027Company of a confirmed 2027 speaker
- Zealand Pharma · 2027Company of a confirmed 2027 speaker
- Dyne Therapeutics · 2027Company of a confirmed 2027 speaker
Confirmed 2027 speakers come from Eli Lilly, Moderna, Biogen, Novo Nordisk, Merck and Alnylam, per the official 2027 speaker page. Gene editing firms such as Intellia, Beam Therapeutics and Prime Medicine also present.
The 2027 sponsor list isn't published yet. The companies below are 2026 sponsors and exhibitors unless marked as 2027 speakers.
Exhibitors at TIDES USA
The 2026 exhibit hall held 88 exhibitors beyond the 52 tiered sponsors, by our count of the official list. The organizer itself cites 170+ sponsors without separating exhibitors.
Exhibitors were mostly peptide and oligonucleotide CDMOs, raw material makers, chromatography and filtration suppliers, and testing labs.
The hall opens with a grand opening and reception, then hosts lunches, breaks and short TIDES Talks, per the conference agenda.
Booths, private meeting rooms and speaking slots are sold through the sponsorship team. Contacts are split by company name, A to F and G to Z.
Exhibitors get access to Lead Insights, Informa's lead scoring dashboard for badge scans and app activity. See our guide to lead retrieval apps for how this compares.
The exhibitor manual goes to booked exhibitors by email rather than as a public download.
Sponsors and partners at TIDES USA
TIDES USA runs a tiered sponsor program with Diamond, Event Partner, Gold, Silver and Bronze levels. The 2026 sponsor page lists 4 Diamond, 3 Event Partner, 7 Gold, 12 Silver and 26 Bronze sponsors.
The why sponsor page groups options into speaking sessions, branded items and booths with meeting rooms. Digital packages add newsletter ads, webinars and list rental.
BioXconomy is the official media partner, and its TIDES USA event page carries sponsored content. The sponsor prospectus sits behind a request form.
Teams comparing tools to plan and measure packages can see our list of event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
TIDES USA attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
The organizer publishes one combined sponsor and exhibitor list. It shows company names by tier, without booth numbers or descriptions.
There's no public attendee list for sale. Registered attendees see the attendee list inside the ConnectMe app, alongside matchmaking and meeting tools.
The ConnectMe app opens to all registered attendees four weeks before the event. It handles meeting requests, messaging, the agenda and digital posters.
The Digital Experience pass also includes the full attendee list, with live and digital-only attendees. Read more about event matchmaking on our glossary.
The organizer warns about housing scams on its travel page. It says TIDES isn't affiliated with outside companies that call to book hotel rooms.
For other ways to see who's coming, read our guide on how to find who's attending an event and our ranking of event intelligence platforms.
See who's attending TIDES USA: Oligonucleotide & Peptide Therapeutics
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at TIDES USA 2027
TIDES USA has named its first 2027 speakers. The home page lists seven early keynotes from PeptiDream, JMM Innovations, Biogen, Intellia, Aralez Bio, Eli Lilly and Moderna.
- Patrick C. ReidPresident and CEO, PeptiDreamKeynote · 2027
- John MaraganoreFounding CEO, Alnylam, and CEO and Principal, JMM InnovationsKeynote · 2027
- Jane GroganExecutive Vice President and Head of Research, BiogenKeynote · 2027
- Kristy WoodSenior Vice President, Technical Operations, Intellia TherapeuticsKeynote · 2027
- Tina BovilleCEO, Aralez BioKeynote · 2027
- Todd MaloneyAssociate Vice President of Analytical Chemistry, Eli Lilly and CompanyKeynote · 2027
- Lin GueyChief Scientific Officer, Therapeutics Research, ModernaKeynote · 2027
More speakers (43)Alla Sigova, Andreas Wagner, Andrew Anzalone and 40 more
- Alla SigovaSenior Vice President, Platform, CAMP4 Therapeutics2027
- Andreas WagnerHead of Liposome Technology, Polymun Scientific2027
- Andrew AnzaloneCo-Founder and Head of Platform, Prime Medicine2027
- Carolyn MazzitelliExecutive Director, Ionis Pharmaceuticals2027
- Dan AppellaSenior Investigator, NIDDK, National Institutes of Health2027
- David J. CraikProfessor of Biomolecular Structure, University of Queensland2027
- Devan ShahFounder and Chief Executive Officer, RNAV8 Bio2027
- Elissa HobertSenior Director of Discovery Technologies, Souffle Therapeutics2027
- Eric FangGeneral Manager and Site Head, Snapdragon Chemistry, a Cambrex Company2027
- Fernando AlbericioResearch Professor, School of Chemistry, University of KwaZulu-Natal2027
- Florence BrunelSenior Principal Scientist, Novo Nordisk2027
- Fran WincottPresident, Wincott & Associates2027
- Ian HugginsSenior Director, Delivery Services, Aerska2027
- Ivan ZlatevExecutive Director of Research, Alnylam Pharmaceuticals2027
- John FinnChief Scientific Officer, Basecamp Research2027
- Julia AltermanAssistant Professor, RNA Therapeutics Institute, UMass Chan Medical School2027
- Kaijiong XiaoPrincipal Scientist, Process Research and Development, Merck2027
- Kevin ColeExecutive Director, Bioproduct Research and Development, Eli Lilly and Company2027
- Li XiaoDirector, Synthetic Molecule Design and Development, Eli Lilly and Company2027
- Lori TroupDirector of Analytical Development, Novo Nordisk2027
- Louise DalbogeChief Scientific Officer, Gubra2027
- Luis BritoVice President, Delivery Platform, Beam Therapeutics2027
- Maged DarwishVice President, Global Regulatory Affairs, CMC, Alnylam Pharmaceuticals2027
- Marc JacobHead of Strategic Development, Chromatography Products, YMC America2027
- Matteo VillainVice President of Peptides and Oligonucleotides, Veranova2027
- Muthiah ManoharanSenior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals2027
- Patrick KnerrVice President, Metabolic Translational Research, Indiana Biosciences Research Institute2027
- Ranganath GopalakrishnanSenior Director and Senior Principal Scientist, Zealand Pharma2027
- Raquel P. DeeringExecutive Director, Cancer Vaccine Research, Moderna2027
- Ratmir DerdaFounder and CSO, 48 Hour Discovery, University of Alberta2027
- Roman HillebrandCo-founder and CTO/COO, OligoStream Industries2027
- Rowshon AlamVice President, Head of Chemistry, Prime Medicine2027
- Rubina ParmarAtlas Venture2027
- Saul Martinez MonteroExecutive Director, RNA Therapeutics, Dyne Therapeutics2027
- Seth AlexanderDirector, Enterprise AI, Prime Medicine2027
- Simona SerbanGlobal Applications Director, Life Sciences, Sunresin2027
- Troels KochChief Technology Officer, Cora Biosciences2027
- William FangVice President of Oligonucleotide and Peptide Development, WuXi TIDES2027
- William KiesmanChief Technology Officer, Judo Bio2027
- Yogesh S. SanghviPresident, Rasayan Inc.2027
- Steven WolkFounder and Chief Consultant, Sinawali Biotechnology Solutions2027
- Mike WebbFounder and CEO, Mike Webb Pharma2027
- Daphne SchaerlaeckensScientific Lab Technician, Aspen Oss2027
Keynotes include Alnylam founding CEO John Maraganore and Intellia's Kristy Wood. The 2027 speaker page lists 55 speakers so far, by our count.
Other 2027 names include Muthiah Manoharan of Alnylam, Andrew Anzalone of Prime Medicine and Julia Alterman of UMass Chan Medical School. Pharma speakers come from Novo Nordisk, Merck and Zealand Pharma.
At the 2026 edition, keynotes came from Robert Langer of MIT and Michael Kopach of Eli Lilly, per Nucleic Acid Insights. Anastasia Khvorova, Kiran Musunuru and Novo Nordisk's James Powell also gave keynotes.
Sponsors can buy speaking sessions, according to the why sponsor page. Scientists without a talk can submit a poster.
Who spoke at TIDES USA: Oligonucleotide & Peptide Therapeutics 2026 (10)
- Robert Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology
- Michael Kopach, Associate Vice President, Synthetic Molecule Design and Development, Eli Lilly and Company
- James Powell, VP, RNAi CMC and Boulder Site Head, Novo Nordisk
- Anastasia Khvorova, Professor, RNA Therapeutics Institute, UMass Chan Medical School
- Vadim Dudkin, Founding Chief Technology Officer, Souffle Therapeutics
- Kiran Musunuru, Barry J. Gertz Professor for Translational Research, Perelman School of Medicine, University of Pennsylvania
- Laura Sepp-Lorenzino, Biotech Executive, Board Member and Industry Advisor, GNMmeds
- Ashok Bhandari, Executive Vice President and Chief Discovery Officer, Protagonist Therapeutics
- Kristine McKinney, Vice President and Head, Cancer Vaccines Research, Moderna
- Andreas Kuhn, Senior Vice President, RNA Biochemistry and CMC Development, BioNTech
Dates, venue and getting there
TIDES USA 2027 runs 26 to 29 April 2027, with the optional obesity workshop on 30 April. It's at the Hynes Convention Center, 900 Boylston Street, Boston.
The Hynes sits in the Back Bay and has its own Green Line subway stop. The travel page says Logan Airport is 10 to 15 minutes away by taxi.
The state is spending $117 million on Hynes building systems over five years, the Boston Globe reported in April 2026.
The official hotel is the Boston Marriott Copley Place, with a discounted room block for attendees.
Tickets and registration for TIDES USA
TIDES USA is a paid professional conference. In November 2026 the industry main conference pass cost $2,999 before 11 December, against a regular $4,199.
The industry pass with recordings and one morning and one afternoon workshop was $3,799 early, or $4,999 regular. Prices checked on the booking page in November 2026.
Add-ons include an industry poster presentation for $150 and the obesity workshop upgrade for $800. Academic, government and young company rates cost less.
Groups of three or more save 10% to 50%, per the group rates page. A Digital Experience pass gives live streams and a year of recordings.
History of TIDES USA
TIDES USA has alternated between Boston and San Diego in recent years. The organizer's 2023 report placed that edition in San Diego.
The 2020 edition ran virtually in September 2020 with over 175 presentations. Boston hosted in 2024 and 2026, and San Diego hosted in 2025.
The 2026 edition ran from 11 to 14 May at the Hynes, per Neuland Labs and the organizer's archived site. Boston hosts again in 2027, two weeks earlier in the calendar.
Resources for exhibitors, sponsors and attendees
These official TIDES USA pages cover registration, exhibiting and travel.
- In-person passes and pricesFor industry, academic and government delegates.
- Digital Experience passesWith live streams and recordings.
- Sponsor and exhibitor listFrom the 2026 edition, by tier.
- Why sponsorFor booths, speaking slots and the prospectus request.
- 2027 speaker listWith names, titles and companies.
- Conference agendaBy day and track.
- Poster presentationsWith abstract and PDF deadlines.
- ConnectMe appFor meetings and networking.
- Hotel bookingAt the Boston Marriott Copley Place.
- Venue and travelFor the Hynes Convention Center.